In this study, we aimed to characterize a cohort of 80 AHA patients by investigating the relationship between antibody profiles and key clinical parameters, including FVIII activity, haemoglobin levels, and inhibitor titres. This evidence concerns the gene F8 and autoimmune hemolytic anemia.